EC Number   |
Inhibitors |
Structure |
|---|
   1.14.13.39 | (4S)-N-(4-amino-5-[aminoethyl]aminopentyl)-N''-nitroguanidine |
- |
   |
| 1.14.13.39 | 1,5,6,7-tetrahydro-2H-azepin-2-imines |
- |
|
| 1.14.13.39 | 1-phenylimidazole |
reversible inhibition of endothelial enzyme, competitive versus L-arginine and tetrahydrobiopterin, no inhibition of cytochrome c reduction |
|
| 1.14.13.39 | 2',3'-dialdehyde of NADPH |
at concentrations of 40times the apparent Km-value or after prolonged incubation, independent of Ca2+/calmodulin, L-arginine or tetrahydrobiopterin, NADPH prevents inhibition, the NADPH-diaphorase activity of the enzyme is less sensitive than the nitric oxide synthase activity |
|
| 1.14.13.39 | 2-aminopyridine derivatives |
highly selective inhibitors |
|
| 1.14.13.39 | 3,4-dihydro-1-isoquinolinamines |
- |
|
| 1.14.13.39 | 3-bromo-7-nitroindazole |
nNOS-specific inhibitor, complete inhibition at 0.01 mM |
|
| 1.14.13.39 | 3-[cis-4'-[(6''-aminopyridin-2''-yl)methyl]pyrrolidin-3'-ylamino]propan-1-ol |
- |
|
| 1.14.13.39 | 4-(3-amino-propoxy)-1-benzopyran-2-one hydrochloric acid salt |
IC50: 0.0076 mM |
|
| 1.14.13.39 | 4-(3-amino-propoxy)-1-benzopyran-2-one hydrochloric acid salt |
IC50: 0.0119 mM |
|
